Prosight Management as of Dec. 31, 2019
Portfolio Holdings for Prosight Management
Prosight Management holds 38 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zimmer Holdings (ZBH) | 8.5 | $20M | 130k | 149.68 | |
| Uniqure Nv (QURE) | 7.5 | $17M | 238k | 71.66 | |
| Arena Pharmaceuticals | 6.5 | $15M | 328k | 45.42 | |
| Kura Oncology (KURA) | 6.2 | $14M | 1.0M | 13.75 | |
| United Therapeutics Corporation (UTHR) | 6.2 | $14M | 161k | 88.08 | |
| Reata Pharmaceuticals Inc Cl A | 5.7 | $13M | 63k | 204.44 | |
| Iovance Biotherapeutics (IOVA) | 4.7 | $11M | 389k | 27.68 | |
| Ac Immune Sa (ACIU) | 4.7 | $11M | 1.2M | 8.52 | |
| Meiragtx Holdings (MGTX) | 4.5 | $10M | 518k | 20.02 | |
| ArQule | 4.0 | $9.0M | 450k | 19.96 | |
| Centene Corporation (CNC) | 3.9 | $9.0M | 143k | 62.87 | |
| Aldeyra Therapeutics (ALDX) | 3.6 | $8.3M | 1.4M | 5.81 | |
| BioMarin Pharmaceutical (BMRN) | 3.4 | $7.8M | 93k | 84.55 | |
| Urogen Pharma (URGN) | 3.2 | $7.3M | 218k | 33.37 | |
| Arena Pharmaceuticals Inc call | 2.8 | $6.5M | 142k | 45.42 | |
| Albireo Pharma | 2.8 | $6.3M | 247k | 25.42 | |
| Envista Hldgs Corp (NVST) | 2.1 | $4.9M | 165k | 29.64 | |
| Personalis Ord (PSNL) | 1.9 | $4.4M | 407k | 10.90 | |
| Anaptysbio Inc Common (ANAB) | 1.7 | $3.8M | 235k | 16.25 | |
| Immunovant (IMVT) | 1.6 | $3.6M | 225k | 15.87 | |
| Organogenesis Hldgs (ORGO) | 1.3 | $3.0M | 618k | 4.81 | |
| Evolus (EOLS) | 1.3 | $2.9M | 237k | 12.17 | |
| Catalyst Biosciences | 1.2 | $2.7M | 392k | 6.81 | |
| Strongbridge Bioph shs usd | 1.1 | $2.6M | 1.3M | 2.09 | |
| R1 Rcm | 1.1 | $2.6M | 200k | 12.98 | |
| Evolent Health (EVH) | 1.1 | $2.5M | 279k | 9.05 | |
| Cigna Corp (CI) | 1.0 | $2.3M | 11k | 204.46 | |
| Molecular Templates | 1.0 | $2.3M | 161k | 13.99 | |
| Cue Biopharma (CUE) | 1.0 | $2.2M | 138k | 15.88 | |
| Allakos Inc put | 0.9 | $2.0M | 21k | 95.36 | |
| Paratek Pharmaceuticals | 0.8 | $1.8M | 450k | 4.03 | |
| Trinet (TNET) | 0.7 | $1.6M | 28k | 56.61 | |
| Kezar Life Sciences | 0.6 | $1.3M | 320k | 4.01 | |
| Teligent | 0.3 | $638k | 1.5M | 0.43 | |
| Axsome Therapeutics | 0.3 | $620k | 6.0k | 103.33 | |
| Milestone Pharmaceuticals (MIST) | 0.3 | $616k | 39k | 16.01 | |
| Bristol Myers Squibb (BMY) | 0.2 | $520k | 8.1k | 64.20 | |
| Apollo Endosurgery | 0.2 | $454k | 159k | 2.85 |
